Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Resistance, Microbial | 32 | 2013 | 856 | 1.780 |
Why?
|
Drug Resistance, Bacterial | 10 | 2020 | 1055 | 1.260 |
Why?
|
Anti-Bacterial Agents | 30 | 2021 | 7408 | 0.850 |
Why?
|
Microbial Sensitivity Tests | 19 | 2021 | 1949 | 0.810 |
Why?
|
Bacterial Infections | 13 | 2020 | 1403 | 0.780 |
Why?
|
Bacteria | 18 | 2020 | 2199 | 0.760 |
Why?
|
Disease Outbreaks | 14 | 2021 | 1758 | 0.610 |
Why?
|
Microbiological Techniques | 1 | 2018 | 98 | 0.590 |
Why?
|
Genes, Bacterial | 7 | 2011 | 1071 | 0.550 |
Why?
|
Cross Infection | 18 | 2020 | 1434 | 0.540 |
Why?
|
R Factors | 9 | 2017 | 44 | 0.530 |
Why?
|
Automation | 1 | 2018 | 580 | 0.520 |
Why?
|
Enterobacteriaceae | 13 | 2017 | 172 | 0.520 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 694 | 0.480 |
Why?
|
Information Services | 1 | 2014 | 235 | 0.420 |
Why?
|
Staphylococcus aureus | 2 | 2021 | 1462 | 0.420 |
Why?
|
Laboratories | 4 | 2014 | 462 | 0.420 |
Why?
|
International Cooperation | 6 | 2014 | 1433 | 0.410 |
Why?
|
Staphylococcal Infections | 3 | 2021 | 1407 | 0.400 |
Why?
|
Communicable Diseases | 5 | 2011 | 878 | 0.370 |
Why?
|
Enterococcus faecalis | 1 | 2011 | 247 | 0.350 |
Why?
|
Tumor Suppressor Proteins | 4 | 2013 | 2802 | 0.340 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2013 | 2058 | 0.290 |
Why?
|
Enterobacteriaceae Infections | 6 | 2017 | 192 | 0.280 |
Why?
|
Lymph Nodes | 4 | 2012 | 3486 | 0.270 |
Why?
|
Information Dissemination | 1 | 2014 | 1131 | 0.250 |
Why?
|
Escherichia coli | 16 | 2016 | 4219 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2012 | 5251 | 0.250 |
Why?
|
Anti-Infective Agents | 2 | 2011 | 981 | 0.240 |
Why?
|
Carbapenems | 2 | 2017 | 123 | 0.240 |
Why?
|
Klebsiella pneumoniae | 6 | 2013 | 255 | 0.240 |
Why?
|
Vermont | 2 | 2021 | 83 | 0.230 |
Why?
|
T-Lymphocytes | 2 | 2012 | 10181 | 0.230 |
Why?
|
Pneumonectomy | 1 | 2011 | 1111 | 0.230 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 586 | 0.220 |
Why?
|
Neoplasm Staging | 5 | 2017 | 11152 | 0.220 |
Why?
|
Diacylglycerol Kinase | 2 | 2012 | 48 | 0.200 |
Why?
|
Lymphocyte Activation | 2 | 2013 | 5496 | 0.200 |
Why?
|
Vancomycin Resistance | 1 | 2002 | 126 | 0.190 |
Why?
|
Cephalosporins | 6 | 2014 | 204 | 0.190 |
Why?
|
Enterobacter | 2 | 2014 | 46 | 0.180 |
Why?
|
World Health Organization | 4 | 2014 | 1312 | 0.180 |
Why?
|
Plasmids | 6 | 1997 | 2275 | 0.180 |
Why?
|
Lung Neoplasms | 5 | 2012 | 13262 | 0.180 |
Why?
|
Homeostasis | 1 | 2011 | 3306 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3725 | 0.180 |
Why?
|
Signal Transduction | 5 | 2013 | 23376 | 0.170 |
Why?
|
Trimethoprim | 5 | 1990 | 84 | 0.170 |
Why?
|
Penicillin Resistance | 8 | 1987 | 82 | 0.170 |
Why?
|
Conjugation, Genetic | 5 | 1993 | 121 | 0.170 |
Why?
|
Gentamicins | 8 | 1990 | 252 | 0.170 |
Why?
|
beta-Lactam Resistance | 2 | 2017 | 74 | 0.160 |
Why?
|
Communicable Diseases, Emerging | 2 | 2013 | 150 | 0.160 |
Why?
|
Software | 5 | 2018 | 4419 | 0.150 |
Why?
|
Mitochondria | 1 | 2011 | 3600 | 0.150 |
Why?
|
Automation, Laboratory | 1 | 2018 | 103 | 0.150 |
Why?
|
Communicable Disease Control | 3 | 2012 | 844 | 0.150 |
Why?
|
Drug Resistance, Multiple | 2 | 2005 | 254 | 0.140 |
Why?
|
Medical Informatics Computing | 1 | 1997 | 24 | 0.140 |
Why?
|
Laboratories, Hospital | 1 | 2018 | 193 | 0.140 |
Why?
|
Escherichia coli Infections | 5 | 2016 | 523 | 0.140 |
Why?
|
Cell Differentiation | 4 | 2013 | 11481 | 0.140 |
Why?
|
Actinomycosis | 1 | 2016 | 20 | 0.140 |
Why?
|
Duodenal Neoplasms | 1 | 2017 | 115 | 0.140 |
Why?
|
Food Microbiology | 2 | 2012 | 76 | 0.130 |
Why?
|
Hepatectomy | 1 | 2019 | 559 | 0.130 |
Why?
|
Internet | 2 | 2014 | 3078 | 0.130 |
Why?
|
DNA Transposable Elements | 2 | 2017 | 756 | 0.120 |
Why?
|
Esophageal Diseases | 1 | 2016 | 168 | 0.120 |
Why?
|
Ampicillin | 6 | 1985 | 141 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2852 | 0.120 |
Why?
|
Population Surveillance | 6 | 2020 | 2608 | 0.120 |
Why?
|
Databases, Factual | 3 | 2014 | 8035 | 0.120 |
Why?
|
Erythromycin | 2 | 1992 | 117 | 0.120 |
Why?
|
Microbiology | 3 | 2001 | 73 | 0.120 |
Why?
|
Cluster Analysis | 6 | 2020 | 2698 | 0.110 |
Why?
|
Bacterial Typing Techniques | 1 | 2014 | 260 | 0.110 |
Why?
|
Poultry | 1 | 1993 | 81 | 0.110 |
Why?
|
Data Collection | 2 | 2014 | 3315 | 0.110 |
Why?
|
Humans | 83 | 2021 | 760621 | 0.110 |
Why?
|
Klebsiella Infections | 2 | 2013 | 147 | 0.110 |
Why?
|
Computer Communication Networks | 1 | 1995 | 294 | 0.110 |
Why?
|
Bacteriuria | 1 | 1993 | 103 | 0.100 |
Why?
|
Trans-Activators | 2 | 2013 | 2860 | 0.100 |
Why?
|
Chondroblastoma | 1 | 2012 | 48 | 0.100 |
Why?
|
Computer Systems | 1 | 2014 | 470 | 0.100 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 508 | 0.100 |
Why?
|
Hospitals, University | 1 | 2014 | 568 | 0.100 |
Why?
|
Sentinel Surveillance | 2 | 2011 | 293 | 0.100 |
Why?
|
Interferon Regulatory Factors | 1 | 2013 | 260 | 0.100 |
Why?
|
Amikacin | 1 | 1991 | 48 | 0.100 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3618 | 0.100 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2012 | 139 | 0.090 |
Why?
|
Multiprotein Complexes | 3 | 2013 | 1120 | 0.090 |
Why?
|
Medical Informatics | 1 | 1998 | 732 | 0.090 |
Why?
|
Genome, Bacterial | 2 | 2017 | 770 | 0.090 |
Why?
|
Aminoglycosides | 3 | 1987 | 163 | 0.090 |
Why?
|
Immunoblotting | 2 | 2011 | 1649 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 650 | 0.090 |
Why?
|
Orbital Neoplasms | 1 | 2012 | 221 | 0.090 |
Why?
|
Keratin-6 | 1 | 2009 | 18 | 0.090 |
Why?
|
Ornithine Decarboxylase | 1 | 2009 | 64 | 0.090 |
Why?
|
Survival Analysis | 3 | 2014 | 10182 | 0.080 |
Why?
|
Lymphatic Metastasis | 3 | 2017 | 2943 | 0.080 |
Why?
|
Mediastinal Neoplasms | 1 | 2012 | 402 | 0.080 |
Why?
|
Streptococcus pyogenes | 1 | 1992 | 294 | 0.080 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6828 | 0.080 |
Why?
|
Shigella | 1 | 2009 | 69 | 0.080 |
Why?
|
Dysentery, Bacillary | 1 | 2009 | 74 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 141 | 0.080 |
Why?
|
Mutation | 3 | 2011 | 29932 | 0.080 |
Why?
|
Proteins | 3 | 2013 | 6029 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 568 | 0.080 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1303 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9276 | 0.080 |
Why?
|
Environmental Monitoring | 1 | 1994 | 1441 | 0.080 |
Why?
|
Drug Resistance | 2 | 2005 | 1617 | 0.070 |
Why?
|
Cephalothin | 7 | 1985 | 35 | 0.070 |
Why?
|
Boston | 4 | 2017 | 9280 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 707 | 0.070 |
Why?
|
Amidohydrolases | 3 | 1975 | 162 | 0.070 |
Why?
|
Desmoglein 2 | 1 | 2007 | 12 | 0.070 |
Why?
|
Serratia marcescens | 2 | 1986 | 48 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2299 | 0.070 |
Why?
|
Bacteremia | 1 | 2014 | 980 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2012 | 4024 | 0.070 |
Why?
|
Bacteriological Techniques | 4 | 1983 | 279 | 0.070 |
Why?
|
Infection Control | 3 | 2020 | 983 | 0.070 |
Why?
|
Rehabilitation Centers | 2 | 1984 | 248 | 0.070 |
Why?
|
Prognosis | 6 | 2019 | 29658 | 0.070 |
Why?
|
Haemophilus influenzae | 2 | 1977 | 180 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2011 | 1630 | 0.060 |
Why?
|
Hepatitis A | 5 | 1985 | 132 | 0.060 |
Why?
|
Organometallic Compounds | 1 | 2009 | 662 | 0.060 |
Why?
|
Cell Separation | 1 | 2011 | 1720 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1648 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6544 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2011 | 830 | 0.060 |
Why?
|
Cephalosporinase | 2 | 1975 | 2 | 0.060 |
Why?
|
Middle Aged | 18 | 2021 | 220352 | 0.060 |
Why?
|
Aged | 13 | 2021 | 169152 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2012 | 1354 | 0.060 |
Why?
|
Public Health | 1 | 1998 | 2653 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1484 | 0.060 |
Why?
|
Legionella | 2 | 1983 | 29 | 0.060 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1985 | 133 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2012 | 6315 | 0.060 |
Why?
|
Penicillinase | 4 | 1992 | 9 | 0.060 |
Why?
|
DNA Restriction Enzymes | 4 | 1986 | 553 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3562 | 0.060 |
Why?
|
Phenotype | 5 | 2013 | 16546 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2651 | 0.060 |
Why?
|
Chloramphenicol | 4 | 1987 | 71 | 0.060 |
Why?
|
Cell Survival | 2 | 2011 | 5797 | 0.060 |
Why?
|
Oncogenes | 1 | 2009 | 1220 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4319 | 0.060 |
Why?
|
Penicillins | 4 | 1987 | 407 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2021 | 26181 | 0.060 |
Why?
|
Salmonella Infections | 2 | 1982 | 171 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3465 | 0.060 |
Why?
|
Bacteriology | 1 | 1983 | 10 | 0.050 |
Why?
|
Child, Preschool | 4 | 2021 | 42063 | 0.050 |
Why?
|
Apoptosis | 2 | 2011 | 9501 | 0.050 |
Why?
|
Infant | 3 | 2021 | 36060 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2019 | 58995 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2012 | 2536 | 0.050 |
Why?
|
Developing Countries | 2 | 2005 | 2868 | 0.050 |
Why?
|
Keratinocytes | 1 | 2007 | 792 | 0.050 |
Why?
|
Algorithms | 2 | 2021 | 13981 | 0.050 |
Why?
|
Animals, Domestic | 1 | 2002 | 57 | 0.050 |
Why?
|
Dihydropyridines | 1 | 2002 | 68 | 0.050 |
Why?
|
beta-Lactamases | 3 | 2017 | 304 | 0.050 |
Why?
|
Quality Control | 3 | 2001 | 828 | 0.050 |
Why?
|
Adult | 18 | 2021 | 219994 | 0.050 |
Why?
|
Hospitals | 2 | 2020 | 3928 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2725 | 0.050 |
Why?
|
Salmonella | 1 | 1982 | 126 | 0.050 |
Why?
|
Female | 21 | 2021 | 391270 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2013 | 9530 | 0.050 |
Why?
|
Animals | 13 | 2013 | 167963 | 0.050 |
Why?
|
Mice | 7 | 2013 | 81208 | 0.050 |
Why?
|
Geography | 2 | 2016 | 661 | 0.050 |
Why?
|
Enterococcus | 1 | 2002 | 160 | 0.050 |
Why?
|
Clone Cells | 2 | 2017 | 1660 | 0.050 |
Why?
|
Urinary Tract Infections | 3 | 1984 | 814 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2011 | 5870 | 0.050 |
Why?
|
Cell Line | 2 | 2012 | 15620 | 0.050 |
Why?
|
Male | 19 | 2021 | 359744 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4353 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4713 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2020 | 80372 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 2 | 1993 | 217 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2283 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11071 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3047 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 58741 | 0.040 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2000 | 108 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2012 | 14372 | 0.040 |
Why?
|
Pharmacy | 1 | 2000 | 92 | 0.040 |
Why?
|
Computers | 3 | 1977 | 595 | 0.040 |
Why?
|
Diarrhea | 1 | 2005 | 1319 | 0.040 |
Why?
|
Sepsis | 5 | 1978 | 2592 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5791 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2002 | 987 | 0.040 |
Why?
|
Serratia | 4 | 1975 | 15 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4550 | 0.040 |
Why?
|
Meningitis, Haemophilus | 1 | 1977 | 21 | 0.040 |
Why?
|
Sex Factors | 2 | 2011 | 10547 | 0.040 |
Why?
|
Haemophilus Infections | 1 | 1977 | 94 | 0.040 |
Why?
|
Sulfonamides | 3 | 1987 | 1977 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9585 | 0.040 |
Why?
|
Tetracycline | 3 | 1986 | 220 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 555 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 77 | 0.040 |
Why?
|
Adolescent | 7 | 2021 | 87810 | 0.040 |
Why?
|
Child | 5 | 2021 | 79806 | 0.040 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2005 | 930 | 0.040 |
Why?
|
Alkaline Phosphatase | 2 | 2019 | 865 | 0.040 |
Why?
|
Macrophages | 1 | 2012 | 5745 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2014 | 4775 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2001 | 749 | 0.030 |
Why?
|
Environment | 1 | 2002 | 1118 | 0.030 |
Why?
|
beta-Lactams | 2 | 1992 | 157 | 0.030 |
Why?
|
Skin | 1 | 2009 | 4466 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2014 | 65017 | 0.030 |
Why?
|
Blood | 2 | 1975 | 586 | 0.030 |
Why?
|
Age Factors | 3 | 2011 | 18416 | 0.030 |
Why?
|
Sulfamethoxazole | 2 | 1985 | 53 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12531 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2010 | 4360 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15289 | 0.030 |
Why?
|
Genetic Variation | 2 | 2017 | 6551 | 0.030 |
Why?
|
Bacteroides | 1 | 1974 | 165 | 0.030 |
Why?
|
Japan | 1 | 2018 | 1369 | 0.030 |
Why?
|
Listeriosis | 1 | 1975 | 148 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12808 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11903 | 0.030 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1993 | 31 | 0.030 |
Why?
|
Candida | 1 | 1974 | 173 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1895 | 0.030 |
Why?
|
Sports Medicine | 3 | 1972 | 242 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2002 | 1885 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9411 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3442 | 0.030 |
Why?
|
Operon | 2 | 1991 | 370 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1975 | 575 | 0.030 |
Why?
|
Salmonella typhimurium | 2 | 1987 | 344 | 0.030 |
Why?
|
Food Handling | 1 | 1993 | 155 | 0.030 |
Why?
|
Orbital Implants | 1 | 2012 | 22 | 0.030 |
Why?
|
Carbenicillin | 3 | 1985 | 15 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3380 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2176 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2012 | 31 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1993 | 763 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2012 | 74 | 0.030 |
Why?
|
Animal Feed | 1 | 2012 | 112 | 0.030 |
Why?
|
Endosonography | 1 | 2016 | 607 | 0.030 |
Why?
|
Renal Dialysis | 4 | 1998 | 1801 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12103 | 0.020 |
Why?
|
Polyethylene | 1 | 2012 | 186 | 0.020 |
Why?
|
Cohort Studies | 2 | 2011 | 41335 | 0.020 |
Why?
|
Mandatory Reporting | 1 | 2012 | 124 | 0.020 |
Why?
|
Pseudomonas Infections | 3 | 1972 | 623 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2007 | 10446 | 0.020 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2012 | 177 | 0.020 |
Why?
|
Genetics, Microbial | 2 | 1983 | 55 | 0.020 |
Why?
|
Venezuela | 1 | 1990 | 75 | 0.020 |
Why?
|
Cholecystitis | 1 | 1971 | 181 | 0.020 |
Why?
|
Finland | 1 | 1992 | 603 | 0.020 |
Why?
|
Species Specificity | 3 | 1986 | 2418 | 0.020 |
Why?
|
Klebsiella | 2 | 1969 | 52 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5799 | 0.020 |
Why?
|
Carrier State | 2 | 1990 | 525 | 0.020 |
Why?
|
Public Health Administration | 1 | 2012 | 243 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2013 | 580 | 0.020 |
Why?
|
Gallbladder Neoplasms | 1 | 1971 | 190 | 0.020 |
Why?
|
Typhoid Fever | 1 | 1971 | 195 | 0.020 |
Why?
|
Inappropriate Prescribing | 1 | 2012 | 209 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 24123 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1296 | 0.020 |
Why?
|
DNA, Bacterial | 2 | 1986 | 1456 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2009 | 151 | 0.020 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2012 | 353 | 0.020 |
Why?
|
Argentina | 1 | 2009 | 245 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1446 | 0.020 |
Why?
|
Massachusetts | 7 | 1985 | 8803 | 0.020 |
Why?
|
Acute Kidney Injury | 3 | 1998 | 1941 | 0.020 |
Why?
|
Cricetinae | 1 | 2012 | 2427 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2012 | 824 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 594 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2013 | 1254 | 0.020 |
Why?
|
Tetracyclines | 1 | 1987 | 65 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39261 | 0.020 |
Why?
|
Cytokines | 2 | 2012 | 7343 | 0.020 |
Why?
|
Keratosis | 1 | 2007 | 80 | 0.020 |
Why?
|
Tobramycin | 2 | 1985 | 67 | 0.020 |
Why?
|
Clindamycin | 1 | 1987 | 140 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 1970 | 522 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2009 | 423 | 0.020 |
Why?
|
Serologic Tests | 2 | 1985 | 383 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 687 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2009 | 940 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1447 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1535 | 0.020 |
Why?
|
Lactams | 1 | 1986 | 154 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2002 | 14660 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2414 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2007 | 697 | 0.020 |
Why?
|
Cephaloridine | 2 | 1975 | 7 | 0.020 |
Why?
|
Occupational Diseases | 1 | 1993 | 1486 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1987 | 407 | 0.020 |
Why?
|
Nursing | 1 | 1984 | 34 | 0.010 |
Why?
|
RNA Interference | 1 | 2013 | 2846 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2913 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22053 | 0.010 |
Why?
|
Hospitals, Special | 1 | 1984 | 90 | 0.010 |
Why?
|
Drug and Narcotic Control | 1 | 2005 | 145 | 0.010 |
Why?
|
China | 1 | 1990 | 2339 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2209 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6771 | 0.010 |
Why?
|
Epidermis | 1 | 2007 | 529 | 0.010 |
Why?
|
Feces | 1 | 1990 | 1455 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1677 | 0.010 |
Why?
|
Drug Synergism | 2 | 1982 | 1754 | 0.010 |
Why?
|
Kidney Transplantation | 3 | 1975 | 4215 | 0.010 |
Why?
|
Nucleotidyltransferases | 1 | 1985 | 244 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2017 | 3826 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 22023 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2141 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 144 | 0.010 |
Why?
|
United States | 6 | 2012 | 72461 | 0.010 |
Why?
|
Space-Time Clustering | 1 | 1982 | 46 | 0.010 |
Why?
|
Protein Precursors | 1 | 2007 | 1134 | 0.010 |
Why?
|
Cattle Diseases | 1 | 1982 | 52 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 3 | 1976 | 1276 | 0.010 |
Why?
|
Salmonella Infections, Animal | 1 | 1982 | 61 | 0.010 |
Why?
|
Swine Diseases | 1 | 1982 | 62 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1984 | 428 | 0.010 |
Why?
|
Staphylococcus | 2 | 1975 | 156 | 0.010 |
Why?
|
Cephamycins | 1 | 1981 | 7 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 2002 | 199 | 0.010 |
Why?
|
Prevalence | 2 | 2005 | 15687 | 0.010 |
Why?
|
Drug Interactions | 1 | 1986 | 1428 | 0.010 |
Why?
|
Serotyping | 1 | 1982 | 324 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5785 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5201 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2326 | 0.010 |
Why?
|
Agar | 1 | 1981 | 55 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12965 | 0.010 |
Why?
|
Stereoisomerism | 1 | 2002 | 617 | 0.010 |
Why?
|
Esters | 1 | 2002 | 211 | 0.010 |
Why?
|
Clinical Enzyme Tests | 2 | 1985 | 115 | 0.010 |
Why?
|
Culture Media | 3 | 1987 | 900 | 0.010 |
Why?
|
Spores, Bacterial | 1 | 1981 | 114 | 0.010 |
Why?
|
Azathioprine | 2 | 1972 | 356 | 0.010 |
Why?
|
Water Microbiology | 2 | 1972 | 113 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2007 | 3094 | 0.010 |
Why?
|
Biological Evolution | 1 | 1986 | 1074 | 0.010 |
Why?
|
Alleles | 1 | 1991 | 6898 | 0.010 |
Why?
|
Water Supply | 2 | 1972 | 206 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1994 | 4412 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5877 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2012 | 3061 | 0.010 |
Why?
|
Molecular Biology | 1 | 1983 | 580 | 0.010 |
Why?
|
Drug Combinations | 1 | 1985 | 2025 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 1987 | 1373 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6479 | 0.010 |
Why?
|
Paris | 1 | 1978 | 50 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3446 | 0.010 |
Why?
|
Time Factors | 6 | 1986 | 40165 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1984 | 1501 | 0.010 |
Why?
|
Diabetes Complications | 1 | 1984 | 1341 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18957 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10827 | 0.010 |
Why?
|
Prednisone | 2 | 1972 | 1565 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2002 | 1257 | 0.010 |
Why?
|
Military Medicine | 1 | 1998 | 186 | 0.010 |
Why?
|
Arteritis | 1 | 1978 | 162 | 0.010 |
Why?
|
Transplantation, Homologous | 3 | 1975 | 4810 | 0.010 |
Why?
|
Cattle | 1 | 1982 | 3847 | 0.010 |
Why?
|
Intestines | 1 | 1985 | 1907 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1977 | 2094 | 0.010 |
Why?
|
Cloxacillin | 1 | 1975 | 6 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5643 | 0.010 |
Why?
|
Penicillin G | 1 | 1975 | 41 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2221 | 0.010 |
Why?
|
Proteus mirabilis | 1 | 1975 | 25 | 0.010 |
Why?
|
Glucosephosphates | 1 | 1974 | 20 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5075 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25942 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2696 | 0.010 |
Why?
|
Extrachromosomal Inheritance | 1 | 1974 | 19 | 0.010 |
Why?
|
Thioglycolates | 1 | 1974 | 38 | 0.010 |
Why?
|
Proteus | 2 | 1976 | 13 | 0.010 |
Why?
|
Polymyxins | 2 | 1976 | 19 | 0.010 |
Why?
|
Hospitalization | 1 | 1975 | 10790 | 0.010 |
Why?
|
Equipment and Supplies, Hospital | 1 | 1974 | 59 | 0.010 |
Why?
|
Risk | 2 | 1984 | 9631 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1978 | 445 | 0.010 |
Why?
|
Hot Temperature | 1 | 1981 | 1435 | 0.010 |
Why?
|
Water Pollution | 2 | 1972 | 33 | 0.010 |
Why?
|
Cephalexin | 1 | 1973 | 38 | 0.010 |
Why?
|
Hydrolysis | 1 | 1975 | 665 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 1984 | 2176 | 0.010 |
Why?
|
Meningitis | 1 | 1975 | 218 | 0.010 |
Why?
|
Thiadiazoles | 1 | 1973 | 64 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1975 | 248 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7475 | 0.010 |
Why?
|
Sulfides | 1 | 1973 | 171 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18137 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54303 | 0.010 |
Why?
|
Swine | 1 | 1982 | 5899 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1977 | 2672 | 0.010 |
Why?
|
Gram-Positive Bacteria | 1 | 1993 | 178 | 0.010 |
Why?
|
Salts | 1 | 1971 | 64 | 0.010 |
Why?
|
Candida albicans | 1 | 1974 | 374 | 0.010 |
Why?
|
Urinary Catheterization | 1 | 1972 | 198 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12159 | 0.010 |
Why?
|
Alanine Transaminase | 3 | 1985 | 606 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1971 | 77 | 0.010 |
Why?
|
Gram-Negative Bacteria | 1 | 1993 | 272 | 0.010 |
Why?
|
Hepatitis B Antigens | 1 | 1970 | 39 | 0.010 |
Why?
|
Complement Fixation Tests | 1 | 1970 | 71 | 0.010 |
Why?
|
Immunodiffusion | 1 | 1970 | 150 | 0.010 |
Why?
|
Dialysis | 2 | 1960 | 75 | 0.010 |
Why?
|
Fluoroquinolones | 1 | 1993 | 308 | 0.010 |
Why?
|
History, 20th Century | 1 | 1998 | 2773 | 0.010 |
Why?
|
Sulfamethizole | 1 | 1969 | 3 | 0.010 |
Why?
|
Sulfathiazoles | 1 | 1969 | 3 | 0.010 |
Why?
|
Nalidixic Acid | 1 | 1969 | 19 | 0.010 |
Why?
|
Nitrofurantoin | 1 | 1969 | 19 | 0.010 |
Why?
|
Streptomycin | 1 | 1969 | 70 | 0.010 |
Why?
|
Kanamycin | 1 | 1969 | 64 | 0.010 |
Why?
|
Jaundice | 2 | 1985 | 97 | 0.010 |
Why?
|
Neomycin | 1 | 1969 | 93 | 0.010 |
Why?
|
Salmonella typhi | 1 | 1971 | 199 | 0.010 |
Why?
|
Cholecystectomy | 1 | 1971 | 406 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1988 | 852 | 0.000 |
Why?
|
Porins | 1 | 1987 | 79 | 0.000 |
Why?
|
Tetrazoles | 1 | 1973 | 905 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1987 | 660 | 0.000 |
Why?
|
Fluid Therapy | 2 | 1960 | 579 | 0.000 |
Why?
|
Hepatovirus | 1 | 1985 | 45 | 0.000 |
Why?
|
Hepatitis A Antibodies | 1 | 1985 | 20 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1983 | 9185 | 0.000 |
Why?
|
Hepatitis Antibodies | 1 | 1985 | 68 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36290 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1985 | 866 | 0.000 |
Why?
|
Medical Records | 1 | 1969 | 1407 | 0.000 |
Why?
|
Leukemia | 1 | 1971 | 1520 | 0.000 |
Why?
|
Lung | 1 | 1981 | 9994 | 0.000 |
Why?
|
Moxalactam | 1 | 1981 | 10 | 0.000 |
Why?
|
Rats | 1 | 1977 | 23711 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1985 | 1529 | 0.000 |
Why?
|
Universities | 1 | 1985 | 992 | 0.000 |
Why?
|
Pneumonia | 1 | 1971 | 2131 | 0.000 |
Why?
|
Graft Rejection | 1 | 1972 | 4426 | 0.000 |
Why?
|
Blood Group Antigens | 1 | 1960 | 187 | 0.000 |
Why?
|
Risk Factors | 1 | 2005 | 74359 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1986 | 4625 | 0.000 |
Why?
|
Colistin | 1 | 1976 | 44 | 0.000 |
Why?
|
Antigens | 1 | 1960 | 1447 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1985 | 4541 | 0.000 |
Why?
|
Ornithine Carbamoyltransferase | 1 | 1972 | 27 | 0.000 |
Why?
|
Heparin | 1 | 1960 | 1652 | 0.000 |
Why?
|
Pneumonia, Staphylococcal | 1 | 1971 | 42 | 0.000 |
Why?
|
Drinking | 1 | 1972 | 199 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1972 | 416 | 0.000 |
Why?
|
Bilirubin | 1 | 1972 | 438 | 0.000 |
Why?
|
Aspergillosis | 1 | 1971 | 243 | 0.000 |
Why?
|
Sodium Chloride | 1 | 1971 | 591 | 0.000 |
Why?
|
Magnesium | 1 | 1971 | 810 | 0.000 |
Why?
|
Hepatitis B | 1 | 1972 | 701 | 0.000 |
Why?
|
Kidney | 1 | 1960 | 7064 | 0.000 |
Why?
|
Cholesterol | 1 | 1972 | 2924 | 0.000 |
Why?
|
Neoplasms | 1 | 1971 | 22072 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1971 | 2093 | 0.000 |
Why?
|
Radiography | 1 | 1971 | 6965 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1971 | 15697 | 0.000 |
Why?
|